Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Barry Richard, holds the title of President & CEO at FILANA THERAPEUTICS, INC..
On 2026-11-18, the insider transacted 44,851 shares.The shares were transacted at a weighted average price of $0.52 per share, resulting in a total market-relevant value of $23K.
Barry Richard (President & CEO) bought $23K of $FLNA
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.